摘要
红花注射液主要原料是中药材红花,然后经过一系列的科学生产工艺对有效成分进行提取,形成注射剂。红花注射液的有效成分主要是少量的红色素和黄色素。通过查阅相关资料,归纳总结了红花注射液的临床应用及不良反应概况,为进一步开展研究和临床合理用药提供理论基础。
The Honghua injection come from TCM safflower, and then go through a series of scientific production process. The active components of safflower is mainly a small amount of red pigment and yellow pigment. The clinical application and adverse reactions of safflower injection was summarized for the further research and the theoretical foundation.
出处
《中医临床研究》
2015年第8期24-25,共2页
Clinical Journal Of Chinese Medicine
关键词
红花注射液
临床应用
不良反应
Safflower
Clinical application
Adverse reactions
